Professional overview
Dr. Xu Fei is an Associate Chief Physician and Deputy Director of the Department of Radiation Oncology at Peking University Third Hospital, specializing in stereotactic body radiation therapy (e.g., CyberKnife), heavy ion radiotherapy, intensity-modulated radiation therapy, radioactive particle implantation, biopsy, tumor ablation, chemotherapy, targeted therapy, and immunotherapy for primary and metastatic tumors of the brain, thorax, abdomen, and pelvis.
Areas of focus
Experience & recognition
- Member of the Chinese Society of Biomedical Engineering Section on Stereotactic Radiotherapy
- Published over 20 peer-reviewed articles as first author
- Authored or co-authored 3 monographs
- Principal investigator of one provincial/municipal key project and two general projects
- Co-investigator on a sub-project of a national major special project
Professional roles
- Member, Chinese Medical Association (CMA)
- Secretary-General, Beijing Municipal Radiotherapy Quality Control Center
- Member, Central Nervous System Tumor Working Group, Radiation Oncology Branch, Beijing Medical Association
- Youth Committee Member, Particle Therapy Society, Professional Committee of Minimally Invasive Therapy, China Anti-Cancer Association (CACA)
- Member, Micro-Noninvasive and Precision Medicine Working Group, China Cancer Rehabilitation Association
Frequently asked questions
What does Dr. Xu Fei specialize in?
Specializes in CyberKnife SBRT, heavy ion radiotherapy, intensity-modulated radiation therapy, radioactive particle implantation, biopsy, tumor ablation, chemotherapy, targeted therapy, and immunotherapy for primary and metastatic tumors of the brain, thorax, abdomen, and pelvis.
Which hospital and department is Dr. Xu Fei in?
Department of Radiation Oncology at Peking University Third Hospital
Sources
- Compiled from public information about the doctor's clinical title, department and areas of focus, rewritten by Find China Doctors.
- Medical licence: National Health Commission doctor registry
Dr. Xu Fei has not reviewed this page.
